Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population

Southern Medical Journal

Volumn 102, Issue 2, 2009, Pages 135-138

  Tejeda Ramirez, Elizabeth ^b   Behani, Majda ^b   Leggiadro, Robert J ^a  

^a LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^b NONE

Author keywords

Community associated MRSA; Pediatric inpatients; Skin and soft tissue infection; South Bronx

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SKIN DISEASE; CHILD; CLINICAL ARTICLE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; FEMALE; HUMAN; INFECTION RISK; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SOFT TISSUE INFECTION; SURGICAL DRAINAGE; COMMUNICABLE DISEASE; DRUG EFFECT; HOSPITAL; INFANT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALS, PEDIATRIC; HOSPITALS, URBAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NEW YORK CITY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 63249123971     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181814d70     Document Type: Article

References (11)

1. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007;357: 380-390.
2. Klevens RM, Morrison MA, Fridkin SK, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006;12:1991-1993.
3. Crawford SE, Daum RS. Epidemic community-associated methicillinresistant Staphylococcus aureus: modern times for an ancient pathogen. Pediatr Infect Dis J 2005;24:459-460.
4. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436 -1444.
5. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005;24:457-458.
6. Gorwitz RJ, Jernigan DB, Powers JH, et al. Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community Strategies for Clinical Management of MRSA in the Community. Summary of an Experts' Meeting Convened by the Centers for Disease Control and Prevention. 2006. Available at: http://www.cdc.gov/ncidod/ dhqp/ar-mrsa-ca.html. Accessed September 4, 2008.
7. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674.
8. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008;27:1-7.
9. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23:123-127.
10. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999;48:707-710.
11. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007;56:325-329.